LabCompass

Nadeen Anabtawi

Medicine · The Ohio State University

Early career · publishing since 2018

Publications

24

Citations

74

Est. group size

~13

Recurring co-author estimate

Active years

9

Publishing since 2018

Research summary
AI-generated

Nadeen Anabtawi's work focuses on how drugs move through and are processed by the body (pharmacokinetics), particularly transporter proteins that affect drug absorption and cancer treatment response. Recent projects examine combination therapies for cancers such as triple-negative breast cancer and blood cancers (leukemia), along with DNA repair mechanisms relevant to chemotherapy drugs like cisplatin. The work also touches on drug safety topics such as poison control reporting and pharmacy education.

Drug transport and pharmacokineticsCancer pharmacology and combination therapiesDNA repair and cell cycle regulationDrug metabolism transporter proteinsPharmacy education and drug safety

Publication output has grown from occasional single papers before 2020 to a more steady pace of roughly 3 publications per year over the last five years, with some year-to-year variation.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 3.2/year recently
172018: 1 publication18192020: 2 publications202021: 5 publications5212022: 3 publications222023: 3 publications232024: 2 publications242025: 5 publications5252026: 3 publications26
Recent publications
Publishes in
  • Journal of Pharmacology and Experimental Therapeutics×4
  • Nature Communications×2
  • Journal of Emergency Medicine×2
  • Faculty of 1000 Research Ltd×2
  • Expert Opinion on Drug Metabolism & Toxicology×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile